Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I / II Study on Infusion of Alloreactive or Stimulated Natural Killer Cells With IL-15 ex Vivo After Haploidentical Transplantation of Hematopoietic Progenitors in Pediatric Patients With Hematological Neoplasms

NCT05304754 is registered in ClinicalTrials.gov with Instituto de Investigación Hospital Universitario La Paz as lead sponsor.

NCT NCT05304754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05304754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I / II Study on Infusion of Alloreactive or Stimulated Natural Killer Cells With IL-15 ex Vivo After Haploidentical Transplantation of Hematopoietic Progenitors in Pediatric Patients With Hematological Neoplasms
Lead sponsor
Instituto de Investigación Hospital Universitario La Paz
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
November 30, 2020
Completion date
July 31, 2026
Enrollment
18 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

high-risk leukemias